KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...

An immuno-oncology targeting panel accurately characterized tumor-resident immune cells and located pathologically and clinically relevant tumor microenvironment features. Cancer development and ...